Hormonal therapy for metastatic renal cell carcinoma combined androgen and provera followed by high dose tamoxifen-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hormonal therapy for metastatic renal cell carcinoma combined androgen and provera followed by high dose tamoxifen

Published:1993-01 Issue:7 Volume:29 Page:997-999
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Papac R.J.,Keohane M.F.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Renal cell carcinoma: basic biology and current approaches to therapy;Belldegrun;Semin Oncol,1991

2. Chemotherapy of renal cell carcinoma: 1983–1989;Yagoda;Semin Oncol,1989

3. Hormones and the kidney: possible therapeutic role of testosterone in a patient with regression of metastases from renal cell adenocarcinoma;Bloom;Br Med J,1964

4. Hormonal therapy and chemotherapy of renal cell carcinoma;Harris;Semin Oncol,1983

5. Treatment of advanced renal cell carcinoma: Traditional methods and innovative approaches;De Kernion;J Urol,1983

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The influence of sex hormones on renal cell carcinoma;Therapeutic Advances in Medical Oncology;2024-01

2. Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK/MAPK in mice;Signal Transduction and Targeted Therapy;2023-03-03

3. Predictive Biomarkers and Novel Targets in the Treatment of Metastatic Renal Cell Carcinoma;Current Medicinal Chemistry;2021-08-16

4. Assessing improvements in metastatic renal cell carcinoma systemic treatments from the pre-cytokine to the immune checkpoint inhibitor eras: a retrospective analysis of real-world data;Japanese Journal of Clinical Oncology;2020-12-15

5. Targeting newly identified ERβ/TGF‐β1/SMAD3 signals with the FDA‐approved anti‐estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma;Molecular Oncology;2018-10-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3